Curated Wealth Partners’s Axsome Therapeutics AXSM Stock Holding History

Curated Wealth Partners’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.1K	Buy	+30,000	New	+$6.51M	﹤0.01%	732

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Curated Wealth Partners's AXSM Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 30,000 shares worth $34.1K. The stake represents ﹤0.01% of the portfolio and ranks #732 among its holdings.

86 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Curated Wealth Partners held 30,000 shares of Axsome Therapeutics worth $34.1K as of Q2 2026.
Axsome Therapeutics was a new Curated Wealth Partners position in Q2 2026.
Axsome Therapeutics made up ﹤0.01% of Curated Wealth Partners's portfolio in Q2 2026, its #732 holding.
86 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.